MedDataX Logo

Acute Myocardial Infarction Study in Northeastern China

NCT ID: NCT04451967

Last Updated: 2020-06-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

3159 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-09-09

Study Completion Date

2022-09-09

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a real-world prospective cohort study aiming to generate knowledge about the characteristics, treatments, and outcomes of hospitalized AMI patients in Jilin Province. The study includes hospitalizations diagnosed of AMI, including ST segment-elevation myocardial infarction (STEMI) and non-ST-segment-elevation myocardial infarction (NSTEMI).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Myocardial Infarction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Transfer after thrombolysis

thrombolysis

Intervention Type PROCEDURE

transfer after thrombolysis for STEMI patients within 6h since onset

Transfer after DAPT

No interventions assigned to this group

Direct transfer

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

thrombolysis

transfer after thrombolysis for STEMI patients within 6h since onset

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

DAPT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients admitted within 7 days of acute myocardial ischemic symptoms with a primary clinical diagnosis of AMI, meet Fourth Universal Definition for Myocardial Infarction (2018)

Exclusion Criteria

* Types 4a and type 5 AMI
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Yanbian University Hospital

UNKNOWN

Sponsor Role collaborator

Dunhua City Hospital in Jilin Province

UNKNOWN

Sponsor Role collaborator

Liaoyuan City Central Hospital

UNKNOWN

Sponsor Role collaborator

Dongliao People's Hospital

UNKNOWN

Sponsor Role collaborator

Songyuan Central Hospital

UNKNOWN

Sponsor Role collaborator

Changling People's Hospital

UNKNOWN

Sponsor Role collaborator

Siping Central People's Hospital

OTHER

Sponsor Role collaborator

The First People's Hospital of Manchu Autonomous County

UNKNOWN

Sponsor Role collaborator

Changchun Center Hospital

UNKNOWN

Sponsor Role collaborator

Nongan People's Hospital

UNKNOWN

Sponsor Role collaborator

Beihua University

OTHER

Sponsor Role collaborator

Jilin Hospital of Integrated Traditional Chinese and Western Medicine

UNKNOWN

Sponsor Role collaborator

Panshi City Hospital

UNKNOWN

Sponsor Role collaborator

Tonghua Central Hospital

UNKNOWN

Sponsor Role collaborator

Baishan Central Hospital

UNKNOWN

Sponsor Role collaborator

Jingyu People's Hospital

UNKNOWN

Sponsor Role collaborator

Meihekou Central Hospital

UNKNOWN

Sponsor Role collaborator

Baicheng Central Hospital

UNKNOWN

Sponsor Role collaborator

Tongyu First Hospital

UNKNOWN

Sponsor Role collaborator

Second Hospital of Jilin University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Bin Liu, Ph.D

Role: PRINCIPAL_INVESTIGATOR

Second Hospital of Jilin University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

The second hospital of Jilin university

Changchun, Jilin, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Tianyi Li, Ph.D

Role: CONTACT

Phone: +8615843024731

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

He Wang, Doctor

Role: primary

References

Explore related publications, articles, or registry entries linked to this study.

Li T, Wu J, Liu J, Sun W, Qi C, Liu B, Wells GA, Wang J; Acute Myocardial Infarction Study in Northeastern China (AMINoC). Protocol for the Acute Myocardial Infarction Study in Northeastern China (AMINoC): a real-world prospective cohort study. BMJ Open. 2021 May 25;11(5):e042936. doi: 10.1136/bmjopen-2020-042936.

Reference Type DERIVED
PMID: 34035090 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SecondJilinU-AMINoC

Identifier Type: -

Identifier Source: org_study_id